Form 4: Myriad Genetics Executive Receives Stock Grant
Insider Transaction (Form 4)
Jennifer Lynne Fox, Chief Legal & Corp Strategy of Myriad Genetics Inc, received 139,267 shares of common stock on November 6, 2026.
Summary
- Grant/award: acquired 139,267 Time-Based Stock Option on November 6, 2026; holds 139,267 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Jennifer Lynne Fox — Officer (Chief Legal & Corp Strategy)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-11-06 | Grant/award | Time-Based Stock Option | 139,267 | — | — | 139,267 |
Key Dates
| Date | Description |
|---|---|
| 2026-11-06 | Grant/award (139,267 shares) |
Keywords
insider transaction, Form 4, MYGN, MYRIAD GENETICS INC, neutral, Jennifer Lynne Fox
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.